12 Jul 2013, BioSpectrum Bureau , BioSpectrum
Singapore: A two month old baby from Germany is the first infant in Europe to receive Sanofi Pasteur-MSD's 6-in-1 paediatric vaccine Hexyon.
Hexyon is fully liquid, ready-to-use, 6-in-1 vaccine to protect infants against six priority diseases: diphtheria, tetanus, whooping cough, Hepatitis B, poliomyelitis and invasive infections caused by Haemophilus influenzae type B.
It has a unique advantage for healthcare professionals in that it is fully liquid (with all components in one syringe) and does not require any reconstitution, so making administration simple and secure.
Hexyon was approved by the European Commission in April this year and national recommendations and funding are being progressed in each country. Germany was granted a recommendation for the vaccine in May 2013 and vaccine supplies began arriving in June.